DAINIPPON SUMITOMO PHARMA
"Green Prism", the symbol of Dainippon Sumitomo Pharma Co., Ltd. is a motif in the design of the "Sun"-expressing a lively sense of energy, moving on toward tomorrow; "Light"-to convey the potential and hope of the future; and "Flower"-engendering the joyous and liberated sensation of basking in good health. A design crafted to embody preeminent research and development powers, a thorough support system, the spirit of challenge, and the other stances of Dainippon Sumitomo Pharma-a company bent on supplying all people with the strength to push on toward an even brighter tomorrow. Emanating from the symbol, furthermore, is the image of a network, steadily spreading out into the world.
DAINIPPON SUMITOMO PHARMA
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1984-01-01
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.ds-pharma.com
Total Employee:
5001+
Status:
Active
Contact:
81 6 6203 5321
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default Domain Not Resolving Amazon DigiCert SSL Amazon CloudFront Amazon Elastic Load Balancing Amazon Tokyo Region My Salesforce Adobe Analytics Amazon Paris Region
Similar Organizations
Dong-A Pharmaceutical
Dong-A Pharm is a leading pharmaceutical company in South Korea.
Dong-A Socio Holdings
Dong-A Socio Holdings has been the leading pharmaceutical company in South Korea.
Farmaku.com
Farmaku.com is a pharmaceutical health care company located in West Jakarta.
Panion & BF Biotech Inc.
Panion & BF Biotech Inc. is a biotech pharmaceutical company with diversified operations
Trans-hit Biomarkers
Trans-hit Biomarkers is a pharmaceutical company located in Laval.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-21 | Tolero Pharmaceuticals | Tolero Pharmaceuticals acquired by Dainippon Sumitomo Pharma | 780 M USD |
| 2012-02-29 | Boston Biomedical | Boston Biomedical acquired by Dainippon Sumitomo Pharma | 2.63 B USD |
| 2009-09-03 | Sunovion Pharmaceuticals | Sunovion Pharmaceuticals acquired by Dainippon Sumitomo Pharma | 2.6 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-01 | Roivant Sciences | Dainippon Sumitomo Pharma investment in Post-IPO Equity - Roivant Sciences | 200 M USD |
| 2020-08-05 | Myovant Sciences | Dainippon Sumitomo Pharma investment in Post-IPO Debt - Myovant Sciences | 200 M USD |
| 2019-07-24 | Drawbridge Health | Dainippon Sumitomo Pharma investment in Debt Financing - Drawbridge Health | N/A |
| 2019-04-05 | AlphaNavi Pharma | Dainippon Sumitomo Pharma investment in Series A - AlphaNavi Pharma | 900 M JPY |
| 2018-10-17 | Meltin MMI | Dainippon Sumitomo Pharma investment in Series B - Meltin MMI | 2.02 B JPY |
| 2018-10-05 | FunPep | Dainippon Sumitomo Pharma investment in Venture Round - FunPep | 460 M JPY |
| 2014-05-22 | Create Vaccine | Dainippon Sumitomo Pharma investment in Venture Round - Create Vaccine | 8.3 M USD |
| 2014-03-27 | Edison Pharmaceuticals | Dainippon Sumitomo Pharma investment in Venture Round - Edison Pharmaceuticals | 50 M USD |
| 2013-10-08 | Healios | Dainippon Sumitomo Pharma investment in Venture Round - Healios | 3 B JPY |
More informations about "Dainippon Sumitomo Pharma"
Leadership - DS Biopharma
Dr John Climax is the co-founder of DS Biopharma, a dermatology and oncology biotech where he is Executive Chairman, and Afimmune, a biotech specialising in rare diseases where he is โฆSee details»
About - DS Biopharma
DS Biopharma (DS), headquartered in Dublin, Ireland, is a privately held drug discovery and development company working on new medicines that improve the quality of life for people with diseases for which existing therapies are ineffective.See details»
DS Biopharma - Crunchbase Company Profile & Funding
DS Biopharma (DS), headquartered in Dublin, Ireland, is a privately held drug discovery and development company working on new medicines that improve the quality of life for people โฆSee details»
DS Biopharma Company Profile 2024: Valuation, Funding
DS Biopharma General Information Description. Developer of novel drugs and therapies intended to treat skin disorders. The company develops new approaches to treat atopic dermatitis and โฆSee details»
DS Pharma Animal Health - Crunchbase
DS Pharma Animal Health Co., Ltd. is an R&D-based pharmaceutical manufacturer for animals. It was established in July 2010 by spinning off the animal health business sector of Sumitomo Dainippon Pharma Co., Ltd. With โฆSee details»
Merger of DS Pharma Biomedical and DS Pharma Promo
Dec 25, 2018 DS Pharma Biomedical Co., Ltd. is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. It is engaged in the research, development, and sales of diagnostics and the manufacturing and sales of โฆSee details»
DS Biopharma - VentureRadar
" DS Biopharma (DS), headquartered in Dublin, Ireland, is a privately held drug discovery and development company working on new medicines that improve the quality of life for people โฆSee details»
DS Biopharma - Craft
DS Biopharma is a biopharmaceutical drug discovery and development company. It develops a proprietary bioactive lipid technology platform that helps to find new approaches to treat atopic โฆSee details»
Merger of DS Pharma Biomedical and DS Pharma Promo
Dec 25, 2018 Susumu Nakajima), today announced a decision that DS Pharma Biomedical will absorb and merge with DS Pharma Promo under the name of โDS Pharma Promo Co., Ltd, โ โฆSee details»
Management - DS Biopharma
He is a Non-Executive Director of Nogra Pharma, Advanced Accelerator Applications, Faron Pharmaceuticals, Summit Therapeutics plc. and an advisor and co-founder to the US medtech โฆSee details»
"DS Pharma Animal Health Co., Ltd." formed
Jul 1, 2010 DS Pharma Animal Health Co., Ltd. (Headquarters: Osaka, Japan; President: Satoshi Ijuin) announced that is has started its business effective from July 1, 2010. As a โฆSee details»
NEW PRODUCTS๏ผDS Pharma Biomedical to Launch Serum-Free โฆ
Apr 28, 2008 DS Pharma Biomedical Co., Ltd., a wholly-owned subsidiary of Dainippon Sumitomo Pharma (DSP), will launch STK2, the world's first serum-free medium for human โฆSee details»
DS Pharma Animal Health Announces Worldโs First Marketing
DS Pharma Animal Health Co., Ltd DS Pharma Animal Health Co., Ltd. is an R&D-focused manufacturer of veterinary medicines that was established in July 2010 by spinning off the โฆSee details»
Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich โฆSee details»
Roadmap for Drug Product Development and Manufacturing of โฆ
Therapeutic biology encompasses different modalities, and their manufacturing processes may be vastly different. However, there are many similarities that run across the different modalities โฆSee details»
Pipeline - DS Biopharma
The DS Biopharma (DS) pharmaceutical compounds are based on a proprietary bioactive lipid technology platform which includes semi-synthetic fatty acids. The molecules in question are โฆSee details»
Contract Development & Manufacturing in Pharmaceuticals
Jul 20, 2020 Samsung Biologics has a notably fast development timeline, offering cell line development to DS manufacturing in nine months, and cell line development to DP โฆSee details»
Pharmaceutical Portfolio - DS Biopharma
DS Biopharma Pharmaceutical Portfolio DS Biopharma (DS) has 2 compounds in development for multiple solid tumors.See details»
Organizational Chart - Sumitomo Pharma
Sumitomo Pharma's organizational chart. Related Contents. Sumitomo Pharma's DX. Sustainability. Research and DevelopmentSee details»